Servier
Servier is a French pharmaceutical company founded in 1954, dedicated to advancing medical science and improving patient outcomes. The company focuses on research and development to create, test, and manufacture both innovative medicinal products and generic medicines. Servier addresses a wide range of therapeutic areas, including oncology, cardiology, metabolic disorders, and central nervous system diseases. By prioritizing patient needs, Servier aims to provide effective treatments with minimal side effects, thereby contributing to global healthcare solutions. The organization is committed to fulfilling a fundamental need in healthcare and fostering therapeutic progress for the future.
Agios Pharmaceuticals is a biopharmaceutical company, discovers and develops therapeutics in the field of cancer metabolism. It also develops drugs that focus on glycolysis, fatty acid metabolism, and autophagy. The company's therapeutics are used in the areas of autoimmune, inflammatory, and neurological diseases. Agios Pharmaceuticals was formerly known as CANCER METABOLISM THERAPEUTICS And changed its name to Agios Pharmaceuticals In April 2008. The company is based in Cambridge, Massachusetts.
Symphogen is the leader in developing recombinant polyclonal antibodies (rpAb), a new class of biopharmaceuticals for the treatment or prophylaxis of serious human diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.